Fermenta Biotech Ltd vs Ganga Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Fermenta Biotech Ltd is ₹ 313.45 as of 04 May 09:39 . The P/E Ratio of Fermenta Biotech Ltd changed from 15.9 on March 2021 to 10.4 on March 2025 . This represents a CAGR of -8.14% over 5 yearsThe P/E Ratio of Ganga Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Fermenta Biotech Ltd changed from ₹ 736.66 crore on March 2021 to ₹ 805.08 crore on March 2025 . This represents a CAGR of 1.79% over 5 yearsThe Market Cap of Ganga Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Fermenta Biotech Ltd for the Dec '25 is ₹ 140.48 crore as compare to the Sep '25 revenue of ₹ 135.66 crore. This represent the growth of 3.55% The revenue of Ganga Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Fermenta Biotech Ltd for the Dec '25 is ₹ 25.89 crore as compare to the Sep '25 ebitda of ₹ 32.07 crore. This represent the decline of -19.27% The ebitda of Ganga Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Fermenta Biotech Ltd changed from ₹ -5.93 crore to ₹ 12.02 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Ganga Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Fermenta Biotech Ltd changed from 13.87 % on March 2021 to 10.78 % on March 2025 . This represents a CAGR of -4.92% over 5 yearsThe Dividend Payout of Ganga Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Fermenta Biotech Ltd

Fermenta Biotech Limited was formerly incorporated as 'Duphar-Interfran Limited' in May, 1951.
The Company name was changed to 'DIL Limited' in September, 2003 and later on, was changed to 'Fermenta Biotech Limited' on October 17, 2019.
The Company is presently engaged in pharmaceuticals, manufacturing and marketing Active Pharmaceutical Ingredients, biotechnology, environmental solutions and renting of properties. Initially, Company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities.
It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London.
These collaborators participated in the equity capital of the Company to the extent of 25% each. In 1964, Company entered into a collaboration with Solvay Duphar to manufacture vitamin D3.

About Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.'95.
In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra. The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

FAQs for the comparison of Fermenta Biotech Ltd and Ganga Pharmaceuticals Ltd

Which company has a larger market capitalization, Fermenta Biotech Ltd or Ganga Pharmaceuticals Ltd?

Market cap of Fermenta Biotech Ltd is 916 Cr while Market cap of Ganga Pharmaceuticals Ltd is 7 Cr

What are the key factors driving the stock performance of Fermenta Biotech Ltd and Ganga Pharmaceuticals Ltd?

The stock performance of Fermenta Biotech Ltd and Ganga Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fermenta Biotech Ltd and Ganga Pharmaceuticals Ltd?

As of May 4, 2026, the Fermenta Biotech Ltd stock price is INR ₹311.4. On the other hand, Ganga Pharmaceuticals Ltd stock price is INR ₹12.0.

How do dividend payouts of Fermenta Biotech Ltd and Ganga Pharmaceuticals Ltd compare?

To compare the dividend payouts of Fermenta Biotech Ltd and Ganga Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.